Why the FDA Is Slow to Remove Drugs

How a liver goes from a brain-dead donor to a living recipient.

Genetically modified crops are finding a foothold in the Global South, producing some unlikely leaders in agritech.

There has been a push toward animal-free alternatives in scientific research. But the success of such alternatives hinges upon whether and where they can outperform standard animal models.

Bioengineers commonly view microbes as reprogrammable “cellular factories” for manufacturing high-value molecules. But what are we throwing away?

A look inside Issue 08.

A new paper from Arc Institute shows that a generative AI model can be used to design viable bacteriophages.